Parkside Financial Bank & Trust’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
Parkside Financial Bank & Trust's NEO Position: Q2 2026 in Review
Parkside Financial Bank & Trust reduced its NeoGenomics (NEO) stake by 25% in Q2 2026, selling an estimated $396 and leaving 126 shares worth $1.84K. The position accounts for ﹤0.01% of the portfolio, ranked #2211.
Parkside Financial Bank & Trust first reported a position in NEO in Q1 2019 and has held it in 29 quarters since. The position peaked at $18K in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Parkside Financial Bank & Trust held 126 shares of NeoGenomics worth $1.84K as of Q2 2026.
- Parkside Financial Bank & Trust sold 41 NeoGenomics shares in Q2 2026, an estimated $396.
- NeoGenomics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2211 holding.
- Parkside Financial Bank & Trust first reported a position in NeoGenomics in Q1 2019 and has held it in 29 quarters since.
- Parkside Financial Bank & Trust's NeoGenomics position peaked at $18K in Q3 2021.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.